Please wait a minute...
Shopping Cart Email List Chinese
Advanced Search Fig/Tab
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Featured Articles  |  Most Downloaded  |  Most Reading
Online Submission Subscribe to Our RSS Content Feed
Front. Med.    2014, Vol. 8 Issue (3) : 362-367    https://doi.org/10.1007/s11684-014-0363-x
RESEARCH ARTICLE
An 84-month observational study of the changes in CD4 T-lymphocyte cell count of 110 HIV/AIDS patients treated with traditional Chinese medicine
Jian Wang1, Biyan Liang1(), Xiaoping Zhang1, Liran Xu2, Xin Deng3, Xiuhui Li4, Lu Fang5, Xinghua Tan6, Yuxiang Mao7, Guoliang Zhang8, Yuguang Wang9
1. TCM Center for AIDS Prevention and Treatment, China Academy of Chinese Medical Sciences, Beijing 100700, China
2. The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China
3. Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning 530011, China
4. Beijing You’an Hospital, Beijing 100054, China
5. Yunnan Provinical Academy of Traditional Chinese Medicine, Kunming 650031, China
6. Guangzhou Eighth People’s Hospital, Guangzhou 510060, China
7. Hebei Hospital of Traditional Chinese Medicine, Shijiazhuang 050011, China
8. Anhui Hospital of Traditional Chinese Medicine, Hefei 230000, China
9. Beijing Ditan Hospital, Beijing 100015, China
 Download: PDF(107 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

This study aimed to evaluate the therapeutic effect of traditional Chinese medicine (TCM) by observing the changes in CD4 T-lymphocyte cell count of 110 cases with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) treated continuously with TCM for 84 months. Information of 110 HIV/AIDS patients from 19 provinces and cities treated with TCM from 2004 to 2013 was collected. Changes in the indexes of CD4 counts (≤200, 201–350, 351–500 and>500 cells/mm3) at five time points (0, 12, 36, 60 and 84 months) and different treatments [TCM and TCM plus antiretroviral therapy (ART)] were compared. Repeated measures test indicated no interaction between group and time (P>0.05). Degrees of increasing and decreasing CD4 count of the two groups at four different frames were statistically significant compared with the baseline. The CD4 count between the two groups was not statistically significant. For CD4 count of≤200 cells/mm3, the mean CD4 count changes were 21 and 28 cells/mm3 per year for the TCM group and TCM plus ART group, respectively. For CD4 count of 201–350 cells/mm3, the mean CD4 count changes were 6 and 25 cells/mm3 per year for the TCM group and TCM plus ART group, respectively. For CD4 count of 351–500 cells/mm3, the mean CD4 count changes were −13 and −7 cells/mm3 per year for the TCM group and TCM plus ART group, respectively. For CD4 count of>500 cells/mm3, the mean CD4 count changes were −34 and −17 cells/mm3 per year for the TCM group and TCM plus ART group, respectively. Long-term use of TCM could maintain or slow the pace of declining CD4 counts in patients with HIV/AIDS, and may achieve lasting effectiveness.
Keywords AIDS      HIV      CD4      traditional Chinese medicine      linear models     
Corresponding Author(s): Biyan Liang   
Online First Date: 02 September 2014    Issue Date: 09 October 2014
 Cite this article:   
Jian Wang,Biyan Liang,Xiaoping Zhang, et al. An 84-month observational study of the changes in CD4 T-lymphocyte cell count of 110 HIV/AIDS patients treated with traditional Chinese medicine[J]. Front. Med., 2014, 8(3): 362-367.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-014-0363-x
https://academic.hep.com.cn/fmd/EN/Y2014/V8/I3/362
Characteristic n (%)
Gender
Male 28 (25.45%)
Female 82 (74.55%)
Age, median years 41.48±8.13
Marriage
Married 103 (93.64%)
Unmarried 5 (4.55%)
Divorced 1 (0.91%)
Widowed 1 (0.91%)
Education
Above college 1 (0.91%)
Senior middle school 4 (3.64%)
Junior high school 62 (56.36%)
Primary school 6 (5.45%)
Preschool 37 (33.64%)
Profession
Farmer 100 (90.91%)
Unemployment 8 (7.27%)
Retirement 1 (0.91%)
Small private business 1 (0.91%)
Route of infection
Paid blood donation 92 (83.64%)
Sexual transmission 12 (10.91%)
Unknown reasons 4 (3.64%)
Intravenous drug 2(1.82%)
Had antiretroviral drugs
CD4 of≤200?cells/mm3 11 (42.31%)
CD4 of 201–350?cells/mm3 13 (29.55%)
CD4 of 351–500?cells/mm3 12 (46.15%)
CD4 of>500?cells/mm3 6 (42.86%)
Tab.1  Demographics of 110 HIV/AIDS patients
Time frame x ¯±s Median
0?month 317.56±167.97 298
12?months 323.89±151.24 325.5
36?months 373.13±191.97 355
60?months 341.45±180.06 331.5
84?months 363.51±179.39 343.5
Tab.2  Overall changes in CD4 count at different time frames in 110 HIV/AIDS patients
Time Time × group Group
CD4 count Mauchly’s W P F P F P F P
≤200?cells/mm3 0.477 0.056 14.109 0.000 0.176 0.950 0.296 0.591
201–350?cells/mm3 0.451 0.000 7.461 0.000 1.269 0.284 2.934 0.094
351–500?cells/mm3 0.711 0.572 2.563 0.043 2.837 0.028 1.035 0.319
>500?cells/mm3 0.434 0.471 5.360 0.001 0.375 0.825 0.100 0.757
Tab.3  Results of repeated measures test and multivariate ANOVA of general linear model
CD4 count (cells/mm3) Group 0 month 12 months 36 months 60 months 84 months
≤200 A(n = 15) 124.67±41.02 227.13±154.16 299.00±184.83 272.60±126.91 279.60±148.93
B(n = 11) 127.36±52.94 244.00±130.99 337.27±202.45 291.27±184.40 325.09±156.39
201–350 A(n = 31) 284.06±40.16 298.81±91.12 334.13±143.01 332.29±168.93 386.42±204.71
B(n = 13) 265.69±42.03 366.31±197.74 427.31±228.36 430.77±214.99 459.46±194.24
351–500 A(n = 14) 405.21±38.79 319.07±139.02 308.79±129.11 361.29±139.65 299.57±128.94
B(n = 12) 399.50±37.10 400.75±138.24 427.00±159.23 318.05±154.32 341.5±168.82
>500 A(n = 8) 641.83±89.78 476.17±110.14 518.83±244.36 348.87±274.50 389.17±98.30
B(n = 6) 635.38±179.71 422.38±171.92 553.50±250.21 424.75±236.80 454.63±197.66
Tab.4  Changes in CD4 count at different time frames of the TCM group and TCM plus ART group
1 National Center for AIDS/STD Control and Prevention, China CDC. Work background of AIDS control and prevention in China. 2014.
2 RS Hogg, KV Heath, B Yip, KJ Craib, MV O’Shaughnessy, MT Schechter, JS Montaner. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998; 279(6): 450−454
https://doi.org/10.1001/jama.279.6.450 pmid: 9466638
3 A Mocroft, S Vella, TL Benfield, A Chiesi, V Miller, P Gargalianos, A d’Arminio Monforte, I Yust, JN Bruun, AN Phillips, JD Lundgren. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352(9142): 1725−1730
https://doi.org/10.1016/S0140-6736(98)03201-2 pmid: 9848347
4 FJ Palella Jr, KM Delaney, AC Moorman, MO Loveless, J Fuhrer, GA Satten, DJ Aschman, SD Holmberg. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338(13): 853−860
https://doi.org/10.1056/NEJM199803263381301 pmid: 9516219
5 R Chou, LH Huffman, R Fu, AK Smits, PT Korthuis; US Preventive Services Task Force. Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2005; 143(1): 55−73
https://doi.org/10.7326/0003-4819-143-1-200507050-00010 pmid: 15998755
6 T Hawkins. Appearance-related side effects of HIV-1 treatment. AIDS Patient Care STDS 2006; 20(1): 6−18
https://doi.org/10.1089/apc.2006.20.6 pmid: 16426151
7 A d’Arminio Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, G Angarano, V Colangeli, A De Luca, G Ippolito, L Caggese, F Soscia, G Filice, F Gritti, P Narciso, U Tirelli, M Moroni. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS 2000; 14(5): 499−507
https://doi.org/10.1097/00002030-200003310-00005 pmid: 10780712
8 IW Park, C Han, X Song, LA Green, T Wang, Y Liu, C Cen, X Song, B Yang, G Chen, JJ He. Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plants. BMC Complement Altern Med 2009; 9(1): 29
https://doi.org/10.1186/1472-6882-9-29 pmid: 19656383
9 A Vickers. Recent advances: complementary medicine. BMJ 2000; 321(7262): 683−686
https://doi.org/10.1136/bmj.321.7262.683 pmid: 10987776
10 J Liu. The use of herbal medicines in early drug development for the treatment of HIV infections and AIDS. Expert Opin Investig Drugs 2007; 16(9): 1355−1364
https://doi.org/10.1517/13543784.16.9.1355 pmid: 17714022
11 J Wang, W Zou, Y Liu. Use of traditional Chinese medicine in HIV/AIDS in China. J Biomed Sci Eng 2010; 3(8): 828−831
https://doi.org/10.4236/jbise.2010.38111
12 CX Chu, YS Xu, J Li, SP Zhao, YF Li. Analysis on first detection of CD4+ T lymphocytes for new HIV-infected persons in Kunming in 2011. Pract Prev Med (Shi Yong Yu Fang Yi Xue) 2013; 20(6): 705−707 (in Chinese)
13 LR Xu, FZ Li, Y He, JZ Guo, D Wang. Sixty- month clinical observation of HIV carriers/ AIDS patients treated with Yiaikang capsule in terms of theirs CD4+ T counts and viral loads. Chin J AIDS STD (Zhongguo Ai Zi Bing Xing Bing) 2010; 16(3): 231−233 (in Chinese)
14 J Wang, Y Liu, W Zou, LR Xu, L Fang, YG Wang, GL Zhang, JM Lu, J Zhou. Clinical observation of effect of traditional Chinese herbs on CD4 count in 807 people living with HIV/AIDS. Chin J AIDS STD (Zhongguo Ai Zi Bing Xing Bing) 2010; 16(3): 208−210 (in Chinese)
15 J Wang, BY Liang, JM Lu, XP Zhang, LR Xu, X Deng, XH Li, L Fang, XH Tan, YX Mao, GL Zhang. A sixty-months study of the change of CD4 T-lymphocyte cell count treated with traditional Chinese medicine in 565 HIV/AIDS patients. Chin J AIDS STD (Zhongguo Ai Zi Bing Xing Bing) 2013; 19(7): 468−471 (in Chinese)
16 YC Ma, GM Qin, GY Zheng, L Liu, LL Zhang, G Liu, XY Mao. Study on combined test with two kinds of different format HIV-Ab ELISAs as a substitute for western blot. Chin J STD/AIDS Prev Cont (Zhongguo Xing Bing Ai Zi Bing Fang Zhi) 2002; 8(6): 335−336 (in Chinese)
17 AIDS group of Society of Infectious Diseases, CMA. Guidelines for treating AIDS. Chin J Infect Dis (Zhonghua Chuan Ran Bing Za Zhi) 2006; 24(2): 137 (in Chinese)
18 Experts Group of Treating HIV/AIDS with TCM of National Health and Family Planning Commission of the People’s Republic of China. Clinical Technology Solutions of National Free Treating HIV/AIDS with TCM Program (Trial). Health Office Medical Care Administration File [2005] No. 19 (in Chinese)
19 DJ Finney. Repeated measurements: what is measured and what repeats? Stat Med 1990; 9(6): 639−644
https://doi.org/10.1002/sim.4780090610 pmid: 2218167
20 SL Yu, HY Xiang. Analysis of Variance and SAS Program of Repeated Data. Beijing: Science Press, 2004: 12−40 (in Chinese)
21 L Liu, Y Gao. Study on the correlation between traditional Chinese medicine syndrome and short-term prognosis of ischemic stroke using logistic regression model and repeated-measures analysis of variance. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2012; 10(9): 983−990 (in Chinese)
https://doi.org/10.3736/jcim20120906 pmid: 22979929
22 H Qiu, GQ Jin, RF Jin, WK Zhao. Analysis of variance of repeated data measured by water maze with SPSS. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2007; 5(1): 101−105 (in Chinese)
https://doi.org/10.3736/jcim20070121 pmid: 17214947
23 HX Zhao, FJ Zhang. Opportunities and challenges of treating HIV/AIDS with TCM plus western medicine. Chin J AIDS STD (Zhongguo Ai Zi Bing Xing Bing) 2008; 14(4): 425−427 (in Chinese)
24 M Badri, R Ehrlich, R Wood, G Maartens. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS 2001; 15(9): 1143−1148
https://doi.org/10.1097/00002030-200106150-00009 pmid: 11416716
25 YW Cen, LC Fu, XH Tan, MM Zhang, BY Ma. Investigation of TCM syndrome in HIV/AIDS patients of Guangdong. Chin Arch Tradit Chin Med (Zhonghua Zhong Yi Yao Xue Kan) 2008; 26(5): 958−961 (in Chinese)
26 J Wang, BY Liang, SY Yan, JM Lu, LR Xu, YG Wang, L Fang, GL Zhang, XH Li, YX Mao, X Deng, XD Li, JW Wang. Clinical observation on 8946 AIDS cases treated by traditional Chinese medicine. J Tradit Chin Med (Zhong Yi Za Zhi) 2011; 52(5): 395−398 (in Chinese)
[1] Qiaoli Shi, Fei Xia, Qixin Wang, Fulong Liao, Qiuyan Guo, Chengchao Xu, Jigang Wang. Discovery and repurposing of artemisinin[J]. Front. Med., 2022, 16(1): 1-9.
[2] Ling Dai, Xiang Gao, Zhihua Ye, Hanmin Li, Xin Yao, Dingbo Lu, Na Wu. The “Traditional Chinese medicine regulating liver regeneration” treatment plan for reducing mortality of patients with hepatitis B-related liver failure based on real-world clinical data[J]. Front. Med., 2021, 15(3): 495-505.
[3] Wenwen Shang, Lei Wu, Rui Xu, Xian Chen, Shasha Yao, Peijun Huang, Fang Wang. Clinical laboratory features of Meigs’ syndrome: a retrospective study from 2009 to 2018[J]. Front. Med., 2021, 15(1): 116-124.
[4] Mengxue Huang, Jingjing Wang, Runshun Zhang, Zhuying Ni, Xiaoying Liu, Wenwen Liu, Weilian Kong, Yao Chen, Tiantian Huang, Guihua Li, Dan Wei, Jianzhong Liu, Xuezhong Zhou. Symptom network topological features predict the effectiveness of herbal treatment for pediatric cough[J]. Front. Med., 2020, 14(3): 357-367.
[5] Qiqi Zhao, Xin Gao, Guangli Yan, Aihua Zhang, Hui Sun, Ying Han, Wenxiu Li, Liang Liu, Xijun Wang. Chinmedomics facilitated quality-marker discovery of Sijunzi decoction to treat spleen qi deficiency syndrome[J]. Front. Med., 2020, 14(3): 335-356.
[6] Yuan Gao, Zhilei Wang, Jinfa Tang, Xiaoyi Liu, Wei Shi, Nan Qin, Xiaoyan Wang, Yu Pang, Ruisheng Li, Yaming Zhang, Jiabo Wang, Ming Niu, Zhaofang Bai, Xiaohe Xiao. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions[J]. Front. Med., 2020, 14(1): 68-80.
[7] Qian Wang, Linqi Zhang. Broadly neutralizing antibodies and vaccine design against HIV-1 infection[J]. Front. Med., 2020, 14(1): 30-42.
[8] Hudan Pan, Yanfang Zheng, Zhongqiu Liu, Zhongwen Yuan, Rutong Ren, Hua Zhou, Ying Xie, Liang Liu. Deciphering the pharmacological mechanism of Guan-Jie-Kang in treating rat adjuvant-induced arthritis using omics analysis[J]. Front. Med., 2019, 13(5): 564-574.
[9] Chia-Wei Li, Yun-Ju Lai, Jennifer L. Hsu, Mien-Chie Hung. Activation of phagocytosis by immune checkpoint blockade[J]. Front. Med., 2018, 12(4): 473-480.
[10] Simone Nüssing, Sneha Sant, Marios Koutsakos, Kanta Subbarao, Thi H.O. Nguyen, Katherine Kedzierska. Innate and adaptive T cells in influenza disease[J]. Front. Med., 2018, 12(1): 34-47.
[11] Jingjing Yan, Shuye Zhang, Jun Sun, Jianqing Xu, Xiaoyang Zhang. Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection[J]. Front. Med., 2017, 11(4): 536-547.
[12] Li Ma, Bin Wang, Yuanxiong Long, Hanmin Li. Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis[J]. Front. Med., 2017, 11(2): 191-202.
[13] Yunfang Liu,Zhiping Yang,Jing Cheng,Daiming Fan. Barriers and countermeasures in developing traditional Chinese medicine in Europe[J]. Front. Med., 2016, 10(3): 360-376.
[14] Yan Ma,Kehua Zhou,Jing Fan,Shuchen Sun. Traditional Chinese medicine: potential approaches from modern dynamical complexity theories[J]. Front. Med., 2016, 10(1): 28-32.
[15] Yan Ma, Shuchen Sun, Chung-Kang Peng. Applications of dynamical complexity theory in traditional Chinese medicine[J]. Front. Med., 2014, 8(3): 279-284.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed